Patients' perspectives on pain
- PMID: 23459087
- PMCID: PMC3584751
- DOI: 10.1310/sci1801-50
Patients' perspectives on pain
Abstract
Nociceptive and neuropathic pain (NP) are common consequences following spinal cord injury (SCI), with large impact on sleep, mood, work, and quality of life. NP affects 40% to 50% of individuals with SCI and is sometimes considered the major problem following SCI. Current treatment recommendations for SCI-NP primarily focus on pharmacological strategies suggesting the use of anticonvulsant and antidepressant drugs, followed by tramadol and opioid medications. Unfortunately, these are only partly successful in relieving pain. Qualitative studies report that individuals with SCI-related long-lasting pain seek alternatives to medication due to the limited efficacy, unwanted side effects, and perceived risk of dependency. They spend time and money searching for additional treatments. Many have learned coping strategies on their own, including various forms of warmth, relaxation, massage, stretching, distraction, and physical activity. Studies indicate that many individuals with SCI are dissatisfied with their pain management and with the information given to them about their pain, and they want to know more about causes and strategies to manage pain. They express a desire to improve communication with their physicians and learn about reliable alternative sources for obtaining information about their pain and pain management. The discrepancy between treatment algorithms and patient expectations is significant. Clinicians will benefit from hearing the patient´s voice.
Keywords: neuropathic pain; nonpharmacological treatment; self-management; spinal cord injury.
Figures


Similar articles
-
Barriers and Facilitators to Optimal Neuropathic Pain Management: SCI Consumer, Significant Other, and Health Care Provider Perspectives.Pain Med. 2020 Nov 1;21(11):2913-2924. doi: 10.1093/pm/pnaa058. Pain Med. 2020. PMID: 32219441
-
Future Treatment of Neuropathic Pain in Spinal Cord Injury: The Challenges of Nanomedicine, Supplements or Opportunities?Biomedicines. 2022 Jun 10;10(6):1373. doi: 10.3390/biomedicines10061373. Biomedicines. 2022. PMID: 35740395 Free PMC article.
-
Pain after spinal cord injury: a review of classification, treatment approaches, and treatment assessment.PM R. 2009 Dec;1(12):1077-90. doi: 10.1016/j.pmrj.2009.07.002. PM R. 2009. PMID: 19797006 Review.
-
Living with chronic neuropathic pain after spinal cord injury: an interpretative phenomenological analysis of community experience.Disabil Rehabil. 2015;37(23):2203-11. doi: 10.3109/09638288.2014.1002579. Epub 2015 Jan 20. Disabil Rehabil. 2015. PMID: 25601144
-
Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous).Ann Phys Rehabil Med. 2009 Mar;52(2):124-41. doi: 10.1016/j.rehab.2008.12.011. Epub 2009 Feb 21. Ann Phys Rehabil Med. 2009. PMID: 19909703
Cited by
-
Outcomes of reconstructive hand surgery in patients with tetraplegia and neuropathic pain.Spinal Cord. 2018 Dec;56(12):1194-1198. doi: 10.1038/s41393-018-0164-1. Epub 2018 Jun 14. Spinal Cord. 2018. PMID: 29904187
-
Auricular acupuncture for spinal cord injury related neuropathic pain: a pilot controlled clinical trial.J Spinal Cord Med. 2017 Jul;40(4):432-438. doi: 10.1080/10790268.2016.1141489. Epub 2016 Feb 15. J Spinal Cord Med. 2017. PMID: 26869339 Free PMC article. Clinical Trial.
-
Pain assessment according to the International Spinal Cord Injury Pain classification in patients with spinal cord injury referred to a multidisciplinary pain center.Spinal Cord. 2016 Oct;54(10):809-815. doi: 10.1038/sc.2015.219. Epub 2016 Jan 12. Spinal Cord. 2016. PMID: 26754471
-
Preliminary study of autologous bone marrow nucleated cells transplantation in children with spinal cord injury.Stem Cells Transl Med. 2014 Mar;3(3):395-404. doi: 10.5966/sctm.2013-0141. Epub 2014 Feb 3. Stem Cells Transl Med. 2014. PMID: 24493853 Free PMC article.
-
Evaluating the effectiveness of antidepressant therapy adjuvant to gabapentin and pregabalin for treatment of SCI-related neuropathic pain.J Spinal Cord Med. 2018 Nov;41(6):637-644. doi: 10.1080/10790268.2017.1415246. Epub 2018 Jan 10. J Spinal Cord Med. 2018. PMID: 29319453 Free PMC article.
References
-
- Norrbrink Budh C, Lund I, Ertzgaard P, et al. Pain in a Swedish spinal cord injury population. Clin Rehabil. 2003;17(6): 685-690 - PubMed
-
- Levi R, Hultling C, Nash MS, Seiger A.The Stockholm spinal cord injury study: 1. Medical problems in a regional SCI population. Paraplegia. 1995;33: 308-315 - PubMed
-
- Siddall PJ, Middleton JW.A proposed algorithm for the management of pain following spinal cord injury. Spinal Cord. 2006;44(2): 67-77 - PubMed
-
- Baastrup C, Finnerup NB.Pharmacological management of neuropathic pain following spinal cord injury. CNS Drugs. 2008;22(6): 455-475 - PubMed
-
- Nayak S, Shiflett S, Schoenberger N, et al. Is acupuncture effective in treating chronic pain after spinal cord injury? Arch Phys Med Rehabil. 2001;82: 1578-1586 - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous